Trump Announces Sweeping Cost Cuts On Obesity Drugs – KXL

WASHINGTON, DC – President Trump is announcing sweeping cost cuts on obesity drugs. The White House says that Eli Lilly, which makes Zepbound, and Novo Nordisk, which manufactures Wegovy, will lower the price of those injectable weight loss drugs to as little as $350 a month for starter doses. The list prices now exceed $1,000.

Trump also says that Medicare will start covering the drugs and that if the Food and Drug Administration approves oral anti-obesity tablets, the lowest dose will cost $149 a month. In exchange, the White House has agreed to give the drugmakers a priority two-month review for certain drugs and a break on tariffs.

All this will start in January when TrumpRX, the administration’s direct-to-consumer website, launches.